Premier Biomedical Inc Share Price OTC Bulletin Board
Equities
US74048K1043
Specialty Chemicals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2018 | 0.04 3.31 | Sales 2019 | 0.01 1.19 | Capitalization | 78.42K 6.53M |
---|---|---|---|---|---|
Net income 2018 | - 0 | Net income 2019 | - 0 | EV / Sales 2018 | 1,61,49,039 x |
Net Debt 2018 | 223K 18.55M | Net Debt 2019 | 89.55K 7.46M | EV / Sales 2019 | 1,17,62,132 x |
P/E ratio 2018 |
-0.74
x | P/E ratio 2019 |
-0.06
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Gabe Vlad
DFI | Director of Finance/CFO | - | - |
William Tynan
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - |
1st Jan change | Capi. | |
---|---|---|
+17.82% | 66.74B | |
+2.85% | 49.42B | |
+19.89% | 42.17B | |
+21.48% | 26.37B | |
+9.99% | 19.17B | |
-1.39% | 16.73B | |
+5.98% | 15.99B | |
-27.02% | 14.85B | |
-12.46% | 14.86B |